Stock data
Cytokinetics, Incorporated (CYTK)
Cytokinetics, Incorporated (CYTK) reported revenue of US$88.04M and net income of -US$784.96M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$88.04M | — | -US$612.26M | -US$784.96M | — |
| 2024 | US$18.47M | — | -US$536.25M | -US$589.53M | — |
| 2023 | US$7.53M | — | -US$496.20M | -US$526.24M | — |
| 2022 | US$94.59M | — | -US$324.20M | -US$388.95M | — |
| 2021 | US$70.43M | — | -US$186.31M | -US$215.31M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$28.62M | -US$198.76M | — |
| 2026-03-31 | US$19.36M | -US$206.03M | — |
| 2025-12-31 | US$17.75M | -US$183.03M | — |
| 2025-09-30 | US$1.94M | -US$306.18M | — |
| 2025-06-30 | US$66.77M | -US$134.37M | — |
| 2025-03-31 | US$1.58M | -US$161.38M | — |
| 2024-12-31 | US$16.93M | -US$150.02M | — |
| 2024-09-30 | US$0.46M | -US$160.54M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.